Hematología y Hemoterapia

Resultados: 309
Tipo Título / Nombre Autor(es) Año
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the PETHEMA-FLUGAZA phase 3 clinical trial Ayala R, Rapado I, Onecha E, Martínez-Cuadrón D, Carreño-Tarragona G, Bergua JM, et al 2021
Concentración de hemoglobina reticulocitaria y ferroterapia en la ERC Deira J, García de la Vega C, Davín E, Arcos MJ 2021
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial Jiménez-Cortegana C, Palazón-Carrión N, Martín García-Sancho A, Nogales-Fernández E, Carnicero-González F, Ríos-Herranz E , et al 2021
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Álvarez RM..., Bermejo N, et al 2021
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM..., Bermejo N, et al 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients Martínez Sánchez MP, Megías-Vericat JE, Rodríguez-Veiga R, Vives S, Bergua JM, Torrent A, et al 2021
Evolving treatment patterns and outcomes in older patients (?60 years) with AML: changing everything to change nothing? Martínez-Cuadrón D, Serrano J, Gil C, Tormo M, Martínez-Sánchez P..., Bergua J, et al 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study Muñoz-González JI, Álvarez-Twose I, Jara-Acevedo M, Zanotti R, Perkins C, Jawhar M, et al 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma Nowakowski GS, Chiappella A, Gascoyne RD, Scott DW, Zhang Q..., Bergua JM, et al 2021
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Palanques-Pastor T, Megías-Vericat JE, Martínez P, López Lorenzo JL, Cornago Navascués J..., Bergua Burgués JM, et al 2021